| 论文题目 | 作者 | 刊物名称 | 发表年 |
|---|---|---|---|
| Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro | Wang X, Burdzhiev NT, Hu H, Li Y, Li J, Lozanova VV, Kandinska MI, Wang M. | Viruses | 2023 |
| High-Intensity Ultraviolet-C Irradiation Efficiently Inactivates SARS-CoV-2 Under Typical Cold Chain Temperature | Li P, Ke X, Leng D, Lin X, Yang W, Zhang H, Tian C, Xu H, Chen Q. | Food Environ Virol. | 2023 |
| Calcium-binding motif-mediated binding of redundant calcium offers a chimeolysin enhanced bactericidal activity and extended host range under physiological conditions | Jia M, Zhou W, Luo D, Xue H, Hu F, Zhang X, Zhao Z, Zhong M, Li X, He J, Wei H, Yang H. | J Antimicrob Chemother | 2023 |
| A novel mAb broadly neutralizes SARS-CoV-2 VOCs in vitro and in vivo, including the Omicron variants | Kan Q, Lin X, Li T, Ke X, Jian X, Zou Z, Zhang W, Wan Z, Xie Q, Shao H, Ye L, Ye J, Qin A, Hou L, Chen Q. | J Med Virol. | 2023 |
| PF-D-Trimer, a protective SARS-CoV-2 subunit vaccine: immunogenicity and application | Zhang Z, Zhou J, Ni P, Hu B, Jolicoeur N, Deng S, Xiao Q, He Q, Li G, Xia Y, Liu M, Wang C, Fang Z, Xia N, Zhang ZR, Zhang B, Cai K, Xu Y, Liu B. | NPJ Vaccines. | 2023 |
| Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan | Cui Q, Shi Z, Yimamaidi D, Hu B, Zhang Z, Saqib M, Zohaib A, Gulnara B, Yersyn M, Hu Z, Li S. | Infect Dis Poverty | 2023 |
| Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells | Zhao K, Guo F, Wang J, Zhong Y, Yi J, Teng Y, Xu Z, Zhao L, Li A, Wang Z, Chen X, Cheng X, Xia Y. | Hepatology | 2023 |
| Structure and molecular mechanism of bacterial transcription activation | Kompaniiets D, Wang D, Yang Y, Hu Y, Liu B. | Trends Microbiol. | 2023 |
| Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins | Dai S, Min YQ, Li Q, Feng K, Jiang Z, Wang Z, Zhang C, Ren F, Fang Y, Zhang J, Zhu Q, Wang M, Wang H, Deng F, Ning YJ. | Nat Commun. | 2023 |
| S100A8/A9: An emerging player in sepsis and sepsis-induced organ injury | Wang Q, Long G, Luo H, Zhu X, Han Y, Shang Y, Zhang D, Gong R. | Biomed Pharmacother. | 2023 |
| Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry | Wang H, Yang Q, Liu X, Xu Z, Shao M, Li D, Duan Y, Tang J, Yu X, Zhang Y, Hao A, Wang Y, Chen J, Zhu C, Guddat L, Chen H, Zhang L, Chen X, Jiang B, Sun L, Rao Z, Yang H. | Nat Commun. | 2023 |
| HostNet: improved sequence representation in deep neural networks for virus-host prediction | Ming Z, Chen X, Wang S, Liu H, Yuan Z, Wu M, Xia H. | BMC Bioinformatics. | 2023 |
| Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China | Li Y, Wu Z, Yan Y, Shi Y, Huang J, Du H, Du Q, Li Y, Lin Y, Liu D, Lu X. | Int J Infect Dis. | 2023 |
| Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir | Jiang X, Su H, Shang W, Zhou F, Zhang Y, Zhao W, Zhang Q, Xie H, Jiang L, Nie T, Yang F, Xiong M, Huang X, Li M, Chen P, Peng S, Xiao G, Jiang H, Tang R, Zhang L, Shen J, Xu Y. | Nat Commun. | 2023 |
| Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants | Tan S, Zhao J, Hu X, Li Y, Wu Z, Lu G, Yu Z, Du B, Liu Y, Li L, Chen Y, Li Y, Yao Y, Zhang X, Rao J, Gao G, Peng Y, Liu H, Yuan Z, Liu J, Wang Q, Hu H, Gao X, Zhou H, Yu H, Xu Y, Yu W, Feng L, Wang M, Shan C, Lu J, Lin J. | Sci Bull (Beijing) | 2023 |
| Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication | Cao Z, Liu C, Peng C, Ran Y, Yao Y, Xiao G, Li E, Chen Z, Chuai X, Chiu S. | Virol Sin. | 2023 |
| Identification of Critical Amino Acids of Coxsackievirus A10 Associated with Cell Tropism and Viral RNA Release during Uncoating | Pei J, Liu RL, Yang ZH, Du YX, Qian SS, Meng SL, Guo J, Zhang B, Shen S. | Viruses. | 2023 |
| Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization | Zhang QY, Zhang HQ, Zhang YN, Zhang ZR, Li XD, Hao MC, Zhang Y, Li JQ, Hu YY, Chen XL, Wang J, Shi YJ, Deng CL, Chen JJ, Ye HQ, Zhang B. | Antiviral Res. | 2023 |
| Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner | Jiang X-M, Xin Q-L, Liu K, Peng X-F, Han S, Zhang L-Y, Liu W, Xiao G-F, Li H, Zhang L-K. | mBio. | 2023 |
| Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults | Chen GL, Yu XY, Luo LP, Zhang F, Dai XH, Li N, Shen ZW, Wu KQ, Lou DF, Peng CG, Jin TH, Huang YM, Shao X, Liu Q, Jiang Q, Guo T, Cao F, Zhu JR, Wu XH, Pei RJ, Deng F, Jiang GP, Li YH, Gao HN, He JX, Zhong-Chen, Peng YC, Li LJ. | Vaccine | 2023 |
科研成果